Target intelligence / Profile preview

AN1-type zinc finger protein 2B (ZFAND2B)

Target
ZFAND2B
Molecular classification
Zinc finger protein, Protein homeostasis factor, Proteasomal regulatory protein, Other
01

Overview

AN1-type zinc finger protein 2B (ZFAND2B) is a zinc finger protein characterized by a conserved AN1 domain containing six cysteine and two histidine residues that coordinate two zinc ions[2][5]. It plays a key role in protein homeostasis by facilitating the ubiquitin-mediated proteasomal degradation of misfolded or aberrant proteins, especially those which fail to properly translocate to the endoplasmic reticulum[3][4]. ZFAND2B is implicated in quality control processes that prevent the accumulation of toxic proteins, and it indirectly regulates signaling pathways such as the insulin-like growth factor receptor pathway by modulating receptor steady-state levels. It has been considered a potential therapeutic target due to its central role in these processes and potential links to protein misfolding disorders and metabolic diseases[4]. There are no established drug interactions or approved targeted therapies, but its biochemical function as a regulatory component of proteasomal degradation systems makes it an attractive subject for research into new therapies for conditions related to protein quality control failure.

Other names
Arsenite-inducible RNA-associated protein-like proteinZFN2B_HUMAN
02

Mechanism of action

Modulation of proteasome activity. Disruption or enhancement of protein translocation and degradation by targeting ZFAND2B.

03

Biological functions

Regulation of protein homeostasisRegulation of signal-mediated protein translocation to the endoplasmic reticulumUbiquitin-mediated proteasomal degradationEndoplasmic reticulum stress responseIndirect regulation of insulin-like growth factor signaling pathway
04

Disease associations

Protein misfolding disordersProtein quality control disordersPotential roles in metabolic and developmental diseases (e.g. microphthalmia, cranioectodermal dysplasia)Other
05

Safety considerations

Not established; possible unintended disruption of protein homeostasis if targeted pharmacologically
06

Biomarkers

Potential marker for endoplasmic reticulum stressQuality control/proteostasis marker (experimental; not established in clinical diagnostics)

Beyond the preview

Go deeper on AN1-type zinc finger protein 2B (ZFAND2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AN1-type zinc finger protein 2B (ZFAND2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call